Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment.
about
Depsides: lichen metabolites active against hepatitis C virusNew perspectives for preventing hepatitis C virus liver graft infection.Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.[Locked outside: cure of chronic hepatitis C using an entry inhibitor].
P2860
Inhibition of hepatitis C entry: too soon to dismiss while many are still being denied treatment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Inhibition of hepatitis C entr ...... still being denied treatment.
@en
Inhibition of hepatitis C entr ...... still being denied treatment.
@nl
type
label
Inhibition of hepatitis C entr ...... still being denied treatment.
@en
Inhibition of hepatitis C entr ...... still being denied treatment.
@nl
prefLabel
Inhibition of hepatitis C entr ...... still being denied treatment.
@en
Inhibition of hepatitis C entr ...... still being denied treatment.
@nl
P2860
P1433
P1476
Inhibition of hepatitis C entr ...... still being denied treatment.
@en
P2093
Bruno Sainz
Susan L Uprichard
P2860
P304
P356
10.1136/GUTJNL-2014-308396
P407
P577
2014-10-06T00:00:00Z